New Paper:
“Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation”
New Paper:
“Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation”
Enzalutamide failing for me now... too bad the drugs they are dreaming of developing won't be available soon enough for me... Research will continue and in 10 years Xtandi may last many years in treatment. Just hope for those who follow.....
One more piece in the puzzle. This piece buys us more time. More time for some of the latest immuno therapies that are finally working to make it thru Phase III Trials keeping us alive for that day.
Injectable T for BAT my work. Looks like maybe 40% of people respond. Do you have info showing more>??>
No such luck there. Just got test results back showing complete mutation load of 0.48% from my CTC and no actionable mutations. Just regular un-mutated aPca that has learned to like enzalutamide environment.
Most anything is worth a try when options start to thin out.